East Jerusalem
Showing 1 - 25 of 1,030
Head and Neck Squamous Cell Carcinoma Trial in East Jerusalem (Carbohydrate-restricted, high-fat diet, Regular composition diet)
Completed
- Head and Neck Squamous Cell Carcinoma
- Carbohydrate-restricted, high-fat diet
- Regular composition diet
-
East Jerusalem, Palestinian Territory, occupiedAugusta Victoria Hospital
Oct 28, 2021
Obesity, Childhood, Health Behavior, Physical Activity Trial (Intervention Program to Promote Healthy Eating and Physical
Active, not recruiting
- Obesity, Childhood
- +3 more
- Intervention Program to Promote Healthy Eating and Physical Activity among Palestinian Female Schoolchildren
- (no location specified)
Jun 16, 2022
Diabetes, Cardiovascular Diseases, Health Behavior Trial (Healthy lifestyle intervention)
Completed
- Diabetes
- +2 more
- Healthy lifestyle intervention
- (no location specified)
Oct 27, 2019
Melanoma Trial in Worldwide (Pembrolizumab, Vibostolimab, V937)
Recruiting
- Melanoma
- Pembrolizumab
- +5 more
-
Los Angeles, California
- +28 more
Jan 25, 2023
Melanoma Trial in Worldwide (Pembrolizumab, Quavonlimab, Vibostolimab)
Recruiting
- Melanoma
- Pembrolizumab
- +4 more
-
Los Angeles, California
- +34 more
Jan 25, 2023
Breast Cancer Trial in Worldwide (Abraxane, Paclitaxel)
Active, not recruiting
- Breast Cancer
-
Adelaide, South Australia, Australia
- +66 more
Aug 10, 2022
Melanoma Trial in Worldwide (Pembrolizumab, Vibostolimab, Pembrolizumab/Quavonlimab)
Recruiting
- Melanoma
- Pembrolizumab
- +5 more
-
Los Angeles, California
- +39 more
Jan 25, 2023
Ovarian Cancer Trial in Worldwide (AZD2281, matching )
Active, not recruiting
- Ovarian Cancer
- AZD2281
- matching placebo
-
Berkeley, California
- +73 more
Dec 19, 2022
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (CSJ117, Placebo)
Recruiting
- Pulmonary Disease, Chronic Obstructive
- CSJ117
- Placebo
-
Andalusia, Alabama
- +59 more
Jul 29, 2022
Extensive Stage Small Cell Lung Cancer Trial (Tarlatamab, Carboplatin, Etoposide)
Recruiting
- Extensive Stage Small Cell Lung Cancer
- Tarlatamab
- +4 more
-
Los Angeles, California
- +37 more
Feb 1, 2023
NSCLC, Advanced Solid Tumors, Gastroesophageal Adenocarcinoma Trial in Worldwide (ABBV-400)
Recruiting
- Non-Small Cell Lung Cancer
- +2 more
-
Santa Monica, California
- +25 more
Jun 27, 2022
Renal Failure, End Stage Renal Disease, Hemodialysis Trial in Worldwide (Human Acellular Vessel (HAV), ePTFE graft)
Active, not recruiting
- Renal Failure
- +3 more
- Human Acellular Vessel (HAV)
- ePTFE graft
-
Phoenix, Arizona
- +38 more
Aug 18, 2022
Diabetes Trial (Motivational Interview support and Dietitian support, Activity tracker plus usual care, Personalized physical
Unknown status
- Diabetes Mellitus
- Motivational Interview support and Dietitian support
- +2 more
- (no location specified)
Feb 3, 2019
Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in Worldwide (Selinexor (combination therapy), Placebo matching for
Recruiting
- Relapsed/Refractory Diffuse Large B-cell Lymphoma
- Selinexor (combination therapy)
- +7 more
-
Chandler, Arizona
- +51 more
May 6, 2022
Nonalcoholic Steatohepatitis Trial in Worldwide (Tirzepatide, Placebo)
Recruiting
- Nonalcoholic Steatohepatitis
- Tirzepatide
- Placebo
-
Birmingham, Alabama
- +119 more
Aug 17, 2022
Tumor Metastasis / Bone and Bones Trial in Worldwide (Data Collection)
Recruiting
- Neoplasm Metastasis / Bone and Bones
- Data Collection
-
Anchorage, Alaska
- +156 more
Aug 22, 2022
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Worldwide (Lemzoparlimab, Azacitidine, Venetoclax)
Recruiting
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndrome (MDS)
- Lemzoparlimab
- +2 more
-
Birmingham, Alabama
- +35 more
Aug 19, 2022
Acute Myocardial Infarction, CHF, ST-Elevation Myocardial Infarction Trial in Worldwide (IK-5001, Saline Solution)
Completed
- Acute Myocardial Infarction
- +2 more
- IK-5001
- Saline Solution
-
Birmingham, Alabama
- +81 more
Aug 9, 2022
Heart Failure Trial in Worldwide (V-Wave Interatrial Shunt, Control)
Active, not recruiting
- Heart Failure
- V-Wave Interatrial Shunt
- Control
-
Gilbert, Arizona
- +110 more
Jan 16, 2023
Diabetes, Health Behaviors Trial in Jerusalem (Attention-control, Community based intervention with resilience training,
Recruiting
- Diabetes
- Health Behaviors
- Attention-control
- +3 more
-
Jerusalem, IsraelBeit-Safafa community center
Jun 16, 2022